SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001654954-21-009294
Filing Date
2021-08-20
Accepted
2021-08-20 16:42:11
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tenx_s3.htm S-3 278226
2 OPINION OF K&L GATES LLP tenx_ex51.htm EX-5.1 12805
3 CONSENTS OF EXPERTS AND COUNSEL tenx_ex231.htm EX-23.1 4379
4 IMAGE tenax.jpg GRAPHIC 4576
5 IMAGE tenx-forms3exhibit51opini000.jpg GRAPHIC 2358
  Complete submission text file 0001654954-21-009294.txt   306556
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-258981 | Film No.: 211194346
SIC: 2834 Pharmaceutical Preparations